Technical Analysis for 0A45 - Moderna Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 107.58 | 2.84% | 2.97 |
Earnings due: May 2
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Gapped Up | Strength | 0.00% |
Get this analysis on your stocks daily!
Moderna Inc. Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a strategic partnership with Caris Life Sciences to advance mRNA-Based oncology therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification
Keywords: Biotechnology Cancer Infectious Diseases Rare Diseases Vaccine Astrazeneca Medical Research Influenza Personalized Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 142.315 |
52 Week Low | 62.55 |
Average Volume | 860 |
200-Day Moving Average | 98.61 |
50-Day Moving Average | 101.86 |
20-Day Moving Average | 105.31 |
10-Day Moving Average | 104.66 |
Average True Range | 3.74 |
RSI (14) | 55.16 |
ADX | 39.42 |
+DI | 26.99 |
-DI | 10.62 |
Chandelier Exit (Long, 3 ATRs) | 102.54 |
Chandelier Exit (Short, 3 ATRs) | 112.99 |
Upper Bollinger Bands | 110.49 |
Lower Bollinger Band | 100.12 |
Percent B (%b) | 0.72 |
BandWidth | 9.85 |
MACD Line | 0.69 |
MACD Signal Line | 0.79 |
MACD Histogram | -0.0945 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 108.51 | ||||
Resistance 3 (R3) | 108.61 | 108.41 | 108.36 | ||
Resistance 2 (R2) | 108.41 | 108.17 | 108.36 | 108.30 | |
Resistance 1 (R1) | 107.99 | 108.02 | 107.89 | 107.89 | 108.25 |
Pivot Point | 107.79 | 107.79 | 107.74 | 107.74 | 107.79 |
Support 1 (S1) | 107.37 | 107.55 | 107.27 | 107.27 | 106.91 |
Support 2 (S2) | 107.17 | 107.40 | 107.12 | 106.86 | |
Support 3 (S3) | 106.75 | 107.17 | 106.81 | ||
Support 4 (S4) | 106.65 |